Activating brain lymphatics to slow Alzheimer's disease progression
Effect of Brain Lymphatic Activation on Alzheimer's Disease Progression
This study is looking at whether improving the drainage system in the brain can help treat Alzheimer's disease by using special techniques to boost a sensor that helps with fluid flow, and it's aimed at finding new ways to support people living with Alzheimer's and similar brain conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10540194 on NIH RePORTER |
What this research studies
This research investigates how enhancing the drainage of brain lymphatics may help in treating Alzheimer's disease. By using mouse models, the study aims to stimulate a specific mechanosensor called Piezo1 to improve brain fluid outflow, which is crucial for brain health. The researchers will explore both genetic and chemical methods to activate this sensor and assess its effects on the development and progression of Alzheimer's disease. The goal is to identify new therapeutic strategies that could benefit patients with Alzheimer's and potentially other neurological conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down the progression of Alzheimer's disease.
How similar studies have performed: While the approach of targeting brain lymphatics is relatively novel, preliminary studies have shown promise in mouse models, indicating potential for success.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Hong, Young-Kwon — University of Southern California
- Study coordinator: Hong, Young-Kwon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.